Researchers are looking into transcranial focused ultrasound (tFUS) as a potential way to treat schizophrenia. This method uses targeted sound waves to reach specific areas of the brain. In studies using rodent models, tFUS was shown to reverse cognitive deficits and prevent behaviors similar to those seen in psychosis.
In these animal models, the treatment also helped restore certain brain markers and improved signaling related to NMDA receptors. When tested in human patients with schizophrenia, the procedure was found to be feasible and generally well tolerated by those involved in the study.
It is important to note that much of this evidence comes from small studies or animal models. The data on how tFUS affects specific symptoms like hallucinations or sensory processing are still preliminary. Because the current evidence is limited and inconsistent, it is too early to know if this will become a standard clinical treatment.
Common questions
Is transcranial focused ultrasound safe for patients with schizophrenia?
In the studies involving human patients, transcranial focused ultrasound (tFUS) was reported to be feasible and generally well tolerated. However, because the clinical evidence is still limited and based on small sample sizes, more research is needed to fully understand its long-term safety and effectiveness.
What did the animal studies show about this treatment?
In rodent models, tFUS was reported to reverse cognitive deficits and prevent psychotic-like behaviors. These results were linked to the restoration of specific brain markers and improved signaling in the prefrontal cortex.
Can this treatment help with hallucinations or other symptoms?
While some preliminary data suggest tFUS might affect circuits related to auditory hallucinations and sensory gating, these findings are currently limited. More research is needed to determine if it can reliably treat specific symptoms like negative symptoms.
